Peroxisome proliferator-activated receptor-α activation attenuates 3-nitropropionic acid induced behavioral and biochemical alterations in rats: Possible neuroprotective mechanisms

被引:47
|
作者
Bhateja, Deepak Kumar [1 ]
Dhull, Dinesh K. [1 ]
Gill, Aneet [1 ]
Sidhu, Akramdeep [1 ]
Sharma, Saurabh [1 ]
Reddy, B. V. Krishna [1 ]
Padi, Satyanarayana S. V. [1 ]
机构
[1] ISF Coll Pharm, Dept Pharmacol, Neuropharmacol Div, Moga 142001, Punjab, India
关键词
Fenofibrate; Huntington's disease; MK886; 3-nitropropionic acid; Oxidative stress; NF-KAPPA-B; PPAR-ALPHA; OXIDATIVE STRESS; MICROGLIAL ACTIVATION; MITOCHONDRIAL TOXIN; HUNTINGTONS-DISEASE; STRIATAL DEGENERATION; EXPERIMENTAL-MODEL; SPINAL-CORD; CELL-DEATH;
D O I
10.1016/j.ejphar.2011.10.029
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Peroxisome proliferators activated receptor is regarded as potential therapeutic targets to control various neurodegenerative disorders. However, none of the study has elucidated its effect in the treatment of Huntington's disease. We explored whether peroxisome proliferators activated receptor-a agonist may attenuate various behavioral and biochemical alterations induced by systemic administration of 3-nitropropionic acid (3-NP), an accepted experimental animal model of Huntington's disease phenotype. Intraperitoneal administration of 3-NP (20 mg/kg., i.p.) for 4 days in rats produced hypolocomotion, muscle incoordination, and cognitive dysfunction. Daily treatment with fenofibrate (100 or 200 mg/kg., p.o.), 30 min prior to 3-NP administration for a total of 4 days, significantly improved the 3-NP induced motor and cognitive impairment. Biochemical analysis revealed that systemic 3-NP administration significantly increased oxidative and nitrosative stress (increase lipid peroxidation, protein carbonyls and nitrite level), lactate dehydrogenase activity whereas, decreased the activities of catalase, superoxide dismutase, reduced glutathione, and succinate dehydrogenase. Fenofibrate treatment significantly attenuated oxidative damage, cytokines and improved mitochondrial complexes enzyme activity in brain. In the present study, MK886, a selective inhibitor of peroxisome proliferators activated receptor-a was employed to elucidate the beneficial effect through either receptor dependent or receptor independent neuroprotective mechanisms. Administration of MK886 (1 mg/kg, i.p.) prior to fenofibrate (200 mg/kg, p.o.) abolished the effect of fenofibrate. The results showed that receptor dependent neuroprotective effects of fenofibrate in 3-NP administered rats provide a new evidence for a role of PPAR-a activation in neuroprotection that is attributed by modulating oxidative stress and inflammation. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:33 / 43
页数:11
相关论文
共 50 条
  • [1] PPAR- α activation attenuates 3-nitropropionic acid induced behavioral and biochemical alterations in rats: Possible neuroprotective mechanisms
    Dhull, D. K.
    Bhateja, D.
    Sidhu, A.
    Reddy, B. V. K.
    Padi, S. S. V.
    Kumar, A.
    MOVEMENT DISORDERS, 2015, 30 : S531 - S531
  • [2] Addressing Peroxisome Proliferator-Activated Receptor-gamma in 3-Nitropropionic Acid-Induced Striatal Neurotoxicity in Rats
    Mansour, Riham M.
    El Sayed, Nesrine S.
    Ahmed, Maha A. E.
    El-Sahar, Ayman E.
    MOLECULAR NEUROBIOLOGY, 2022, 59 (07) : 4368 - 4383
  • [3] Addressing Peroxisome Proliferator-Activated Receptor-gamma in 3-Nitropropionic Acid-Induced Striatal Neurotoxicity in Rats
    Riham M. Mansour
    Nesrine S. El Sayed
    Maha A. E. Ahmed
    Ayman E. El-Sahar
    Molecular Neurobiology, 2022, 59 : 4368 - 4383
  • [4] Peroxisome proliferator-activated receptor-γ activation attenuates harmaline-induced cognitive impairments in rats
    Aghaei, Iraj
    Hajali, Vahid
    Haghani, Masoud
    Vaziri, Zohreh
    Moosazadeh, Mahmmod
    Shabani, Mohammad
    JOURNAL OF CLINICAL NEUROSCIENCE, 2019, 59 : 276 - 283
  • [5] Telmisartan attenuates peritoneal fibrosis via peroxisome proliferator-activated receptor-γ activation in rats
    Su, Xuesong
    Yu, Rui
    Yang, Xu
    Zhou, Guangyu
    Wang, Yanqiu
    Li, Li
    Li, Detian
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2015, 42 (06) : 671 - 679
  • [6] The Role of Peroxisome Proliferator-Activated Receptor-α Activation in Acute Myocardial Damage Induced by Isoproterenol in Rats
    Jie, Yuan
    Jian, Wu
    Zhi-Gang, Hang
    Xue-Kuan, Zhong
    Ling-Wang, Zhou
    Bo, Yu
    CIRCULATION, 2010, 122 (02) : E96 - E96
  • [7] Effects of Peroxisome Proliferator-Activated Receptor-γ Activation on Apoptosis in Rats with Acute Pancreatitis
    Ping Xu
    Xiao-Li Lou
    Cheng Chen
    Zhi-Wen Yang
    Digestive Diseases and Sciences, 2013, 58 : 3516 - 3523
  • [8] Effects of Peroxisome Proliferator-Activated Receptor-γ Activation on Apoptosis in Rats with Acute Pancreatitis
    Xu, Ping
    Lou, Xiao-Li
    Chen, Cheng
    Yang, Zhi-Wen
    DIGESTIVE DISEASES AND SCIENCES, 2013, 58 (12) : 3516 - 3523
  • [9] Antihypertensive Effects of Peroxisome Proliferator-Activated Receptor-β Activation in Spontaneously Hypertensive Rats
    Jose Zarzuelo, Maria
    Jimenez, Rosario
    Galindo, Pilar
    Sanchez, Manuel
    Nieto, Ana
    Romero, Miguel
    Maria Quintela, Ana
    Lopez-Sepulveda, Rocio
    Gomez-Guzman, Manuel
    Bailon, Elvira
    Rodriguez-Gomez, Isabel
    Zarzuelo, Antonio
    Galvez, Julio
    Tamargo, Juan
    Perez-Vizcaino, Francisco
    Duarte, Juan
    HYPERTENSION, 2011, 58 (04) : 733 - U437
  • [10] Effect of resveratral on 3-nitropropionic acid-induced biochemical and behavioural changes: possible neuroprotective mechanisms
    Kumar, Puneet
    Sreenivasulu Venketswera Padi, Satyanaryana
    Sreenivasulu Naidu, Pattipati
    Kumar, Anil
    BEHAVIOURAL PHARMACOLOGY, 2006, 17 (5-6): : 485 - 492